Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration

AbstractIschemic cell death during a myocardial infarction leads to a multiphase reparative response in which the damaged tissue is replaced with a fibrotic scar produced by fibroblasts and myofibroblasts. This also induces geometrical, biomechanical, and biochemical changes in the uninjured ventricular wall eliciting a reactive remodeling process that includes interstitial and perivascular fibrosis. Although the initial reparative fibrosis is crucial for preventing rupture of the ventricular wall, an exaggerated fibrotic response and reactive fibrosis outside the injured area are detrimental as they lead to progressive impairment of cardiac function and eventually to heart failure. In this review, we summarize current knowledge of the mechanisms of both reparative and reactive cardiac fibrosis in response to myocardial infarction, discuss the potential of inducing cardiac regeneration through direct reprogramming of fibroblasts and myofibroblasts into cardiomyocytes, and review the currently available and potential future therapeutic strategies to inhibit cardiac fibrosis. Graphical abstractReparative response following a myocardial infarction. Hypoxia-induced cardiomyocyte death leads to the activation of myofibroblasts and a reparative fibrotic response in the injured area. Right top In adult mammals, the fibrotic scar formed at the infarcted area is permanent and promotes reactive fibrosis in the uninjured myocardium. Right bottom In teleost fish and newts and in embryonic and neonatal mammals, the initial formation of a fibrotic scar is followed by regeneration of the cardiac muscle tissue. Induction of post-infarction cardiac regeneration in adult mammals is currently the target of intensive research and drug discovery attempts

[1]  Kenneth L. Jones,et al.  High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling , 2015, Nature Communications.

[2]  A. Leask Getting to the heart of the matter: new insights into cardiac fibrosis. , 2015, Circulation research.

[3]  E. Olson,et al.  A Dynamic Notch Injury Response Activates Epicardium and Contributes to Fibrosis Repair , 2011, Circulation research.

[4]  N. Frangogiannis,et al.  Fibroblasts in myocardial infarction: a role in inflammation and repair. , 2014, Journal of molecular and cellular cardiology.

[5]  D. Lindemann,et al.  A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. , 2012, Journal of molecular and cellular cardiology.

[6]  R. Markwald,et al.  Recruitment of New Cells into the Postnatal Heart , 2006, Annals of the New York Academy of Sciences.

[7]  Johan Verjans,et al.  Myocardial remodeling after infarction: the role of myofibroblasts , 2010, Nature Reviews Cardiology.

[8]  D. Srivastava,et al.  Direct reprogramming of fibroblasts into cardiomyocytes for cardiac regenerative medicine. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[9]  B. Ebert,et al.  Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. , 2015, Cell stem cell.

[10]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[11]  J. Balligand,et al.  HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome. , 2013, Cardiovascular research.

[12]  N. Bursac,et al.  Stoichiometry of Gata4, Mef2c, and Tbx5 Influences the Efficiency and Quality of Induced Cardiac Myocyte Reprogramming , 2015, Circulation research.

[13]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[14]  M. Hiroe,et al.  Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. , 2010, American journal of physiology. Heart and circulatory physiology.

[15]  R. Graham,et al.  Cardiac Regeneration Therapies - Targeting Neuregulin 1 Signalling. , 2016, Heart, lung & circulation.

[16]  Ofer Binah,et al.  Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure , 2011, Journal of cellular and molecular medicine.

[17]  F. Rodríguez-Pascual,et al.  The profibrotic role of endothelin-1: is the door still open for the treatment of fibrotic diseases? , 2014, Life sciences.

[18]  F. Slack,et al.  The let-7 family of microRNAs. , 2008, Trends in cell biology.

[19]  Gang Wang,et al.  Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy , 2011, Nature Cell Biology.

[20]  G. Fonarow,et al.  Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.

[21]  N. Turner,et al.  Cardiac fibroblasts: at the heart of myocardial remodeling. , 2009, Pharmacology & therapeutics.

[22]  I. Karakikes,et al.  Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling , 2013, Journal of the American Heart Association.

[23]  B. Hinz,et al.  The Single-Molecule Mechanics of the Latent TGF-β1 Complex , 2011, Current Biology.

[24]  N. Frangogiannis,et al.  IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium , 2013, The Journal of Immunology.

[25]  J. Burnett,et al.  Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases , 2002, Circulation research.

[26]  S. Conway,et al.  Origin, development, and differentiation of cardiac fibroblasts. , 2014, Journal of molecular and cellular cardiology.

[27]  K. Chien,et al.  Programming and reprogramming a human heart cell , 2015, The EMBO journal.

[28]  Xiaoxia Qi,et al.  Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.

[29]  J. Burnett,et al.  Natriuretic peptides and therapeutic applications , 2007, Heart Failure Reviews.

[30]  W. Koch,et al.  Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts , 2014, Pharmacology research & perspectives.

[31]  Ivan C. Gerling,et al.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart , 2013, Nature Reviews Cardiology.

[32]  V. Dzau,et al.  Direct reprogramming of cardiac fibroblasts to cardiomyocytes using microRNAs. , 2014, Methods in molecular biology.

[33]  Shinsuke Yuasa,et al.  Induction of human cardiomyocyte-like cells from fibroblasts by defined factors , 2013, Proceedings of the National Academy of Sciences.

[34]  Yanjie Lu,et al.  Simvastatin alleviates cardiac fibrosis induced by infarction via up‐regulation of TGF‐β receptor III expression , 2015, British journal of pharmacology.

[35]  E. Finch,et al.  MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes , 2012, Circulation research.

[36]  R. Kalluri,et al.  The origin of fibroblasts and mechanism of cardiac fibrosis , 2010, Journal of cellular physiology.

[37]  Arjun Deb,et al.  Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair , 2012, The EMBO journal.

[38]  H. Baharvand,et al.  Ascorbic acid promotes the direct conversion of mouse fibroblasts into beating cardiomyocytes. , 2015, Biochemical and Biophysical Research Communications - BBRC.

[39]  E. Olson,et al.  Transient Regenerative Potential of the Neonatal Mouse Heart , 2011, Science.

[40]  I. Barthélémy,et al.  Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells , 2015, Stem cells international.

[41]  W. Blankesteijn,et al.  Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing , 2012, Fibrogenesis & tissue repair.

[42]  J. Rysä,et al.  Thrombospondins, potential drug targets for cardiovascular diseases. , 2013, Basic & clinical pharmacology & toxicology.

[43]  P. Kohl,et al.  Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions. , 2016, Journal of molecular and cellular cardiology.

[44]  Hiroyuki Tsutsui,et al.  Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction , 2002, Circulation.

[45]  村岡 直人 MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures , 2015 .

[46]  A. Leask Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.

[47]  N. Bursac,et al.  Transcription Factors MYOCD, SRF, Mesp1 and SMARCD3 Enhance the Cardio-Inducing Effect of GATA4, TBX5, and MEF2C during Direct Cellular Reprogramming , 2013, PloS one.

[48]  R. Stewart,et al.  Lineage Reprogramming of Fibroblasts into Proliferative Induced Cardiac Progenitor Cells by Defined Factors. , 2016, Cell stem cell.

[49]  Milena B. Furtado,et al.  Cardiogenic Genes Expressed in Cardiac Fibroblasts Contribute to Heart Development and Repair , 2014, Circulation research.

[50]  D. Kass Cardiac Role of Cyclic-GMP Hydrolyzing Phosphodiesterase Type 5: From Experimental Models to Clinical Trials , 2012, Current Heart Failure Reports.

[51]  B. Hinz,et al.  The myofibroblast matrix: implications for tissue repair and fibrosis , 2013, The Journal of pathology.

[52]  C. I. Spencer,et al.  Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. , 2014, Cell reports.

[53]  Cizhong Jiang,et al.  Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails , 2015, Cell Research.

[54]  F. Harrell,et al.  Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure , 2014, Journal of the American Heart Association.

[55]  D. Brenner,et al.  Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. , 2014, The Journal of clinical investigation.

[56]  Y. Soini,et al.  Thrombospondin-4 expression is rapidly upregulated by cardiac overload. , 2008, Biochemical and biophysical research communications.

[57]  Ryan M. Anderson,et al.  Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes , 2010, Nature.

[58]  K. Red-Horse,et al.  Developmental Heterogeneity of Cardiac Fibroblasts Does Not Predict Pathological Proliferation and Activation , 2014, Circulation research.

[59]  R. Weissleder,et al.  Molecular imaging of myocardial infarction. , 2006, Journal of molecular and cellular cardiology.

[60]  Stephanie L. K. Bowers,et al.  Cardiac Fibroblast: The Renaissance Cell , 2009, Circulation research.

[61]  Yao Sun,et al.  Platelet-derived growth factor involvement in myocardial remodeling following infarction. , 2011, Journal of molecular and cellular cardiology.

[62]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[63]  A. Geinoz,et al.  The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, Journal of Cell Biology.

[64]  Md. Abul Hassan Samee,et al.  Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis , 2016, Cell.

[65]  A. SullengerBruce,et al.  RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit+ Cardiac Progenitor Cells , 2015 .

[66]  M. Harmsen,et al.  Bone marrow‐derived myofibroblasts contribute functionally to scar formation after myocardial infarction , 2008, The Journal of pathology.

[67]  B. Sullenger,et al.  RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit + Cardiac Progenitor Cells , 2015 .

[68]  Greg G. Wang,et al.  Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. , 2016, Cell stem cell.

[69]  M. Lindsey,et al.  The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. , 2016, Journal of molecular and cellular cardiology.

[70]  J. Nerbonne,et al.  MicroRNA-133a Protects Against Myocardial Fibrosis and Modulates Electrical Repolarization Without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts , 2010, Circulation research.

[71]  Thomas Thum,et al.  Noncoding RNAs and myocardial fibrosis , 2014, Nature Reviews Cardiology.

[72]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[73]  B. Aronow,et al.  A Thrombospondin-Dependent Pathway for a Protective ER Stress Response , 2012, Cell.

[74]  Jimena Canales,et al.  Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation. , 2011, Biochimica et biophysica acta.

[75]  J. Rysä,et al.  Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: Novel extracellular matrix modulating factors in cardiac remodelling , 2012, Annals of medicine.

[76]  N. Frangogiannis,et al.  The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.

[77]  R. Kalluri,et al.  Origins of cardiac fibroblasts. , 2010, Circulation research.

[78]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[79]  D. Srivastava,et al.  Recent advances in direct cardiac reprogramming. , 2015, Current opinion in genetics & development.

[80]  C. Yin,et al.  In vivo cardiac reprogramming using an optimal single polycistronic construct. , 2015, Cardiovascular research.

[81]  E. Finch,et al.  MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. , 2015, Circulation research.

[82]  E. Olson,et al.  Macrophages are required for neonatal heart regeneration. , 2014, The Journal of clinical investigation.

[83]  A. Lenzi,et al.  Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications , 2015, Journal of Endocrinological Investigation.

[84]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[85]  M. Keating,et al.  Heart Regeneration in Zebrafish , 2002, Science.

[86]  J. Rysä,et al.  (Pro)renin Receptor Triggers Distinct Angiotensin II-Independent Extracellular Matrix Remodeling and Deterioration of Cardiac Function , 2012, PloS one.

[87]  R. Ross,et al.  Integrins and integrin-related proteins in cardiac fibrosis. , 2016, Journal of molecular and cellular cardiology.

[88]  Guofeng Ren,et al.  Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling , 2007, Circulation.

[89]  Li Qian,et al.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.

[90]  K. Kivirikko,et al.  Connective Tissue Growth Factor Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in Pressure Overload–Induced Heart Failure , 2014, Hypertension.

[91]  A. Åsberg,et al.  Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats , 2002, Basic Research in Cardiology.

[92]  E. Olson,et al.  Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes , 2015, Proceedings of the National Academy of Sciences.

[93]  W. Gong,et al.  Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor β-induced Smad signaling , 2014, Frontiers of Medicine.

[94]  Xiao-Fan Wang,et al.  Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction , 2010, Circulation research.

[95]  D. Theodorescu,et al.  Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? , 2012, Life sciences.

[96]  Y. Soini,et al.  Divergent Effects of Losartan and Metoprolol on Cardiac Remodeling, C‐kit+ Cells, Proliferation and Apoptosis in the Left Ventricle after Myocardial Infarction , 2009, Clinical and translational science.

[97]  M. Ieda,et al.  Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. , 2014, Annual review of physiology.

[98]  H. Shimokawa,et al.  Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. , 2012, Journal of cardiology.

[99]  David Milan,et al.  Inefficient Reprogramming of Fibroblasts into Cardiomyocytes Using Gata4, Mef2c, and Tbx5 , 2012, Circulation research.

[100]  Maria-Teresa Piccoli,et al.  Non-coding RNAs as modulators of the cardiac fibroblast phenotype. , 2016, Journal of molecular and cellular cardiology.

[101]  J. Molkentin,et al.  Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.

[102]  J. Molkentin,et al.  Myofibroblasts: trust your heart and let fate decide. , 2014, Journal of molecular and cellular cardiology.

[103]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[104]  J. Erler,et al.  Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. , 2016, Cardiovascular research.

[105]  J. Rysä,et al.  Intramyocardial BNP Gene Delivery Improves Cardiac Function Through Distinct Context-Dependent Mechanisms , 2011, Circulation. Heart failure.

[106]  Filipa Pinto,et al.  Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. , 2013, Journal of molecular and cellular cardiology.

[107]  H. Ruskoaho Atrial natriuretic peptide: synthesis, release, and metabolism. , 1992, Pharmacological reviews.

[108]  M. Daemen,et al.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.

[109]  M. Bader Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. , 2010, Annual review of pharmacology and toxicology.

[110]  Andrew W. Trafford,et al.  Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling , 2016, Journal of molecular and cellular cardiology.

[111]  N. Frangogiannis Matricellular proteins in cardiac adaptation and disease. , 2012, Physiological reviews.

[112]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[113]  Jae-Bong Park,et al.  Neuregulin induces CTGF expression in hypertrophic scarring fibroblasts , 2012, Molecular and Cellular Biochemistry.

[114]  C. I. Spencer,et al.  Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts. , 2016, Cell stem cell.

[115]  N. Frangogiannis,et al.  The pathogenesis of cardiac fibrosis , 2013, Cellular and Molecular Life Sciences.

[116]  W. Koch,et al.  Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice , 2014, Pharmacology research & perspectives.

[117]  J. C. Belmonte,et al.  Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation , 2010, Nature.

[118]  M. Watkins TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice , 2010 .

[119]  J. Epstein,et al.  Inhibition of TGFβ Signaling Increases Direct Conversion of Fibroblasts to Induced Cardiomyocytes , 2014, PloS one.

[120]  S. Keirstead,et al.  Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain. , 2013, Cardiovascular research.

[121]  Li Qian,et al.  Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State , 2013, Stem cell reports.

[122]  S. Heymans,et al.  TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'. , 2010, Journal of molecular and cellular cardiology.

[123]  L. Wilkins Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure , 2015, Journal of the American Heart Association.

[124]  M. Pucéat,et al.  Origins of cardiac fibroblasts. , 2016, Journal of molecular and cellular cardiology.

[125]  C. von Kalle,et al.  Bone marrow-derived cells contribute to infarct remodelling. , 2006, Cardiovascular research.

[126]  E. Olson,et al.  Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors , 2014, Development.

[127]  S. Pikkarainen,et al.  GATA transcription factors in the developing and adult heart. , 2004, Cardiovascular research.

[128]  Kenji Nakamura,et al.  Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[129]  R. Henkelman,et al.  Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy. , 2011, Cardiovascular research.

[130]  F. Prósper,et al.  Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. , 2015, Journal of the American College of Cardiology.

[131]  N. Frangogiannis,et al.  The Extracellular Matrix Modulates Fibroblast Phenotype and Function in the Infarcted Myocardium , 2012, Journal of Cardiovascular Translational Research.

[132]  S. Rosenkranz TGF-β1 and angiotensin networking in cardiac remodeling , 2004 .

[133]  A. Leask Potential Therapeutic Targets for Cardiac Fibrosis: TGF&bgr;, Angiotensin, Endothelin, CCN2, and PDGF, Partners in Fibroblast Activation , 2010, Circulation research.

[134]  R. Becker,et al.  Regeneration of the ventricular myocardium in amphibians , 1974, Nature.

[135]  G. Nguyen Renin, (pro)renin and receptor: an update. , 2011, Clinical science.

[136]  Arjun Deb,et al.  Cardiac fibroblast in development and wound healing. , 2014, Journal of molecular and cellular cardiology.

[137]  A. Cooney,et al.  "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors. , 2014, The Journal of thoracic and cardiovascular surgery.

[138]  Gerard Pasterkamp,et al.  Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction , 2011, Circulation research.

[139]  J Michael DiMaio,et al.  Making steady progress on direct cardiac reprogramming toward clinical application. , 2013, Circulation research.

[140]  Ning Wang,et al.  Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. , 2009, Cardiovascular research.

[141]  Peter Kohl,et al.  Fibroblast–myocyte electrotonic coupling: Does it occur in native cardiac tissue?☆ , 2014, Journal of molecular and cellular cardiology.

[142]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[143]  Kathryn E. Hentges,et al.  The functional diversity of essential genes required for mammalian cardiac development , 2014, Genesis.

[144]  Keiichi Fukuda,et al.  MiR‐133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures , 2014, The EMBO journal.

[145]  E. Small,et al.  Transcriptional control of cardiac fibroblast plasticity. , 2016, Journal of molecular and cellular cardiology.

[146]  D. Srivastava,et al.  Cardiac reprogramming: from mouse toward man. , 2013, Current opinion in genetics & development.

[147]  N. Rosenthal,et al.  Revisiting Cardiac Cellular Composition. , 2016, Circulation research.

[148]  Igor R Efimov,et al.  Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. , 2009, Heart rhythm.

[149]  Yonggang Ma,et al.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. , 2016, Journal of molecular and cellular cardiology.

[150]  JaanaRysä,et al.  GATA-4 Is an Angiogenic Survival Factor of the Infarcted Heart , 2010 .

[151]  C. Long,et al.  Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. , 2014, Journal of molecular and cellular cardiology.

[152]  I. Dixon,et al.  Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility. , 2011, American journal of physiology. Cell physiology.

[153]  N. Mercader,et al.  Pan-epicardial lineage tracing reveals that epicardium derived cells give rise to myofibroblasts and perivascular cells during zebrafish heart regeneration. , 2012, Developmental biology.

[154]  Gianpaolo Zerbini,et al.  MiR‐133a regulates collagen 1A1: Potential role of miR‐133a in myocardial fibrosis in angiotensin II‐dependent hypertension , 2012, Journal of cellular physiology.

[155]  N. Frangogiannis,et al.  Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.

[156]  Thomas K Borg,et al.  Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. , 2007, American journal of physiology. Heart and circulatory physiology.